Develops antibody-based therapies for severe autoimmune diseases.
| Title |
|---|
| Legal Counsel, Germany Full Time · 5+ YOE Germany · Remote |
| Global Medical Director, (San Paulo, Brazil) Full Time · 8+ YOE Brazil · Hybrid |
| Medical Science Liaison, (San Paulo, Brazil) Full Time Brazil · Onsite |
| Medical Science Liaison, (Rio de Janeiro, Brazil) Full Time Rio de Janeiro, Rio de Janeiro, Brazil · Onsite |
| Global Medical Indication Lead Full Time · 4+ YOE United States or Belgium or Switzerland · Remote |
| Senior Medical Director Indication Lead Full Time · $296K-$444K · 3+ YOE United States · Remote |
| Gross to Net Finance Lead Full Time · $176K-$264K · 12+ YOE Boston, Massachusetts, United States · Hybrid |
| Global BIS Finance Lead Full Time · 15+ YOE Belgium · Onsite |
| Clinical Operations Development Lead Full Time · 10+ YOE United States · Remote |
| Associate Director Field Based Market Access, Germany Full Time · 10+ YOE Germany · Remote |
| Clinical Operations Development Lead Full Time · 15+ YOE Gent or Belgium · Hybrid |
| (Associate) Director, Patient Advocacy and Public Policy Germany Full Time · 8+ YOE Germany · Remote |
| Activities | Antibody engineeringBiopharmaceutical developmentClinical trial managementDrug commercializationImmunology research |
| Headquarters | NL |
| Industries | BiotechnologyPharmaceuticals |
| Name | argenx |
| Employees | 2,373 |
| Type | Public |
| Subsidiaries | argenx B.V.argenx US, Inc.argenx Japan KKargenx Canada Inc.argenx Switzerland SA |
| Tagline | Develops antibody-based therapies for severe autoimmune diseases. |
| Founded | 2,008 |
| Website | argenx.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | ARGX |